Fernandez-Fernandez R, Lozano C, Reuben R, Ruiz-Ripa L, Zarazaga M, Torres C
Microorganisms. 2023; 11(5).
PMID: 37317303
PMC: 10221470.
DOI: 10.3390/microorganisms11051329.
Ballester M, Ballester J, Belaich J
Microb Ecol. 2013; 3(4):289-303.
PMID: 24233666
DOI: 10.1007/BF02010737.
Martirani L, Varcamonti M, Naclerio G, De Felice M
Microb Cell Fact. 2002; 1(1):1.
PMID: 12076356
PMC: 115367.
DOI: 10.1186/1475-2859-1-1.
Eppert I, Gotz H, Busse M, Scherer S
Appl Environ Microbiol. 1997; 63(12):4812-7.
PMID: 9406400
PMC: 168805.
DOI: 10.1128/aem.63.12.4812-4817.1997.
Sahl H
Appl Environ Microbiol. 1994; 60(2):752-5.
PMID: 8135526
PMC: 201380.
DOI: 10.1128/aem.60.2.752-755.1994.
Purification of the viridicin produced by Aerococcus viridans.
Ballester J, Ballester M, Belaich J
Antimicrob Agents Chemother. 1980; 17(5):784-8.
PMID: 7396467
PMC: 283876.
DOI: 10.1128/AAC.17.5.784.
Antifungal activity of some Discomycetes. II. Fractionation and partial characterization of the antifungal substance produced by Ciboria rufo-fusca.
Pesando D, Gueho E
Mycopathologia. 1982; 77(3):153-7.
PMID: 7070486
DOI: 10.1007/BF00518800.
Production, purification, and properties of a bacteriocin from Staphylococcus aureus isolated from saliva.
Nakamura T, Yamazaki N, Taniguchi H, Fujimura S
Infect Immun. 1983; 39(2):609-14.
PMID: 6832811
PMC: 347995.
DOI: 10.1128/iai.39.2.609-614.1983.
Production, purification, and preliminary characterization of a gonococcal growth inhibitor produced by a coagulase-negative staphylococcus isolated from the urogenital flora.
Beaudet R, Bisaillon J, Saheb S, Sylvestre M
Antimicrob Agents Chemother. 1982; 22(2):277-83.
PMID: 6821457
PMC: 183725.
DOI: 10.1128/AAC.22.2.277.
Production of a bacteriocin, ulceracin 378, by Corynebacterium ulcerans.
Abrehem K, Zamiri I
Antimicrob Agents Chemother. 1983; 24(2):262-7.
PMID: 6688939
PMC: 185148.
DOI: 10.1128/AAC.24.2.262.
Purification and characterization of a bacteriocin from Bacteroides fragilis.
Hayes T, CUNDY K, Fernandes P, Hoober J
J Bacteriol. 1983; 155(3):1171-7.
PMID: 6350264
PMC: 217813.
DOI: 10.1128/jb.155.3.1171-1177.1983.
Nature and properties of a Staphylococcus epidermidis bacteriocin.
Jetten A, Vogels G
J Bacteriol. 1972; 112(1):243-50.
PMID: 5079064
PMC: 251404.
DOI: 10.1128/jb.112.1.243-250.1972.
Characterization and extrachromosomal control of bacteriocin production in Staphylococcus aureus.
Jetten A, Vogels G
Antimicrob Agents Chemother. 1973; 4(1):49-57.
PMID: 4791482
PMC: 444503.
DOI: 10.1128/AAC.4.1.49.
Group A streptococcal bacteriocin. Production, purification, and mode of action.
Tagg J, Dajani A, Wannamaker L, Gray E
J Exp Med. 1973; 138(5):1168-83.
PMID: 4744922
PMC: 2139428.
DOI: 10.1084/jem.138.5.1168.
Characteristics of the killing effect of a Staphylococcus epidermidis bacteriocin.
Jetten A, Vogels G
Antonie Van Leeuwenhoek. 1974; 40(1):177-83.
PMID: 4545195
DOI: 10.1007/BF00394565.
Mode of action of a Staphylococcus epidermidis bacteriocin.
Jetten A, Vogels G
Antimicrob Agents Chemother. 1972; 2(6):456-63.
PMID: 4274969
PMC: 444339.
DOI: 10.1128/AAC.2.6.456.
Purification and biochemical properties of a bacteriocin from Actinobacillus actinomycetemcomitans.
Stevens R, Lillard S, HAMMOND B
Infect Immun. 1987; 55(3):692-7.
PMID: 3818091
PMC: 260395.
DOI: 10.1128/iai.55.3.692-697.1987.
Inhibition of caries in hamsters treated with staphylococcin 1580.
FitzGerald R, Morhart R, Marquez C, Adams B
Infect Immun. 1986; 54(2):288-90.
PMID: 3770944
PMC: 260157.
DOI: 10.1128/iai.54.2.288-290.1986.
Viridins, bacteriocins of alpha-hemolytic streptococci: isolation, characterization, and partial purification.
Dajani A, Tom M, Law D
Antimicrob Agents Chemother. 1976; 9(1):81-8.
PMID: 1259394
PMC: 429479.
DOI: 10.1128/AAC.9.1.81.
Bacteriocin of a group B streptococcus: partial purification and characterization.
Tagg J, Dajani A, Wannamaker L
Antimicrob Agents Chemother. 1975; 7(6):764-72.
PMID: 1155919
PMC: 429224.
DOI: 10.1128/AAC.7.6.764.